June 19, 2013
Financial engineering failed dramatically in the financial crisis, but maybe it could be used to help persuade institutions to invest in cancer research.
Professor Andrew Lo of MIT’s Sloan School of Management explains the long view with columnist John Authers.
Lo says, “We have, literally tens of thousands of scientists that have many ideas and
are starved for resources. If we can get the funding that they need, we think
they can make breakthroughs in cancer in as little as 5 to 10 years from now,” to which Authers adds some thoughts and concludes,”It’s a very pleasant change to start to think of financial engineering as a possible cause for good – but really, why not?”
For more video content from the Financial Times, visit http://www.FT.com/video